NASDAQ:MEDS Wellgistics Health (MEDS) Stock Price, News & Analysis $0.96 -0.07 (-6.69%) As of 09/3/2026 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsNews and TrendsOwnershipSEC Filings About Wellgistics Health Stock (NASDAQ:MEDS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Wellgistics Health alerts:Sign Up Key Stats Today's Range$0.95▼$1.0350-Day Range$0.96▼$3.5252-Week Range$0.82▼$86.00Volume51,989 shsAverage Volume707,534 shsMarket Capitalization$3.08 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Wellgistics Health, Inc. is a healthcare technology and pharmaceutical services company focused on improving access to prescription medications in the United States. The company works across the healthcare supply chain to connect pharmaceutical manufacturers, healthcare providers, pharmacies and patients through technology-enabled distribution and support services. Its offerings include pharmaceutical distribution and related services designed to help independent pharmacies and other healthcare organizations obtain and dispense prescription medicines. Wellgistics has also highlighted solutions supporting specialty and high-demand therapies, including medications used in diabetes and weight-management treatment, subject to applicable regulatory and prescribing requirements. The company’s business is primarily focused on the U.S. healthcare market. Wellgistics Health’s operations include its Wellgistics Rx platform and related technology and fulfillment capabilities, which are intended to streamline medication access, ordering and delivery for participating pharmacies and providers. Publicly available information about its broader operating history and leadership is limited.AI Generated. May Contain Errors. Read More Wellgistics Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks1st Percentile Overall ScoreMEDS MarketRank™: Wellgistics Health scored higher than 1% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingWellgistics Health has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageWellgistics Health has only been the subject of 1 research reports in the past 90 days.Read more about Wellgistics Health's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Wellgistics Health is -0.02, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Wellgistics Health is -0.02, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for MEDS. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldWellgistics Health does not currently pay a dividend.Dividend GrowthWellgistics Health does not have a long track record of dividend growth. News and Social Media0.0 / 5News SentimentN/A Search InterestOnly 1 people have searched for MEDS on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Wellgistics Health insiders have not sold or bought any company stock.Percentage Held by Insiders29.10% of the stock of Wellgistics Health is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions5.68% of the stock of Wellgistics Health is held by institutions.Read more about Wellgistics Health's insider trading history. Receive MEDS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Wellgistics Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MEDS Stock News HeadlinesWellgistics Health (NASDAQ:MEDS) Shares Up 4.6% - Here's What HappenedAugust 26, 2026 | americanbankingnews.comDataMEDS AI Officially Begins Trading Under Stock Symbol ‘MEDS’ on the NASDAQ Capital MarketsJuly 22, 2026 | usatoday.comA new income category is drawing serious money - here's whyForbes recently called a new category of exchange-traded income funds a 'golden era,' and Bloomberg noted the eye-popping yields are fueling a boom among everyday investors. Three years ago, barely a dozen of these funds existed - today there are more than 100, holding over $140 billion. These funds trade on the NYSE and NASDAQ and are built to generate monthly income. Some investors are targeting $5,000 a month with roughly one-tenth of the nest egg Wall Street says you need.September 4 at 1:00 AM | Investors Alley (Ad)WELLGISTICS HEALTH, INC. OFFICIALLY CHANGES CORPORATE NAME TO DATAMEDS AI, INC.July 21, 2026 | prnewswire.comWellgistics Health, Inc.: Wellgistics Health Announces Updated Record Date for Distribution of Dream Bowl 2026 Meme Coin to StockholdersJuly 20, 2026 | finanznachrichten.deRubenstein Public Relations Named Agency of Record for Wellgistics Health, Inc.July 16, 2026 | globenewswire.comWellgistics Health appoints Brett Thompson as consulting CTOJuly 15, 2026 | seekingalpha.comWellgistics Health, Inc.: Wellgistics Health Appoints Brett Thompson as Chief Technology OfficerJuly 15, 2026 | finanznachrichten.deSee More Headlines MEDS Stock Analysis - Frequently Asked Questions How have MEDS shares performed this year? Wellgistics Health's stock was trading at $20.00 on January 1st, 2026. Since then, MEDS stock has decreased by 95.2% and is now trading at $0.9611. How were Wellgistics Health's earnings last quarter? Wellgistics Health, Inc. (NASDAQ:MEDS) released its earnings results on Tuesday, August, 19th. The company reported ($5.50) EPS for the quarter. The business had revenue of $7.79 million for the quarter. When did Wellgistics Health's stock split? Shares of Wellgistics Health reverse split on Tuesday, May 26th 2026.The 1-50 reverse split was announced on Wednesday, May 20th 2026. The number of shares owned by shareholders was adjusted after the market closes on Monday, May 25th 2026. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split. How do I buy shares of Wellgistics Health? Shares of MEDS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Wellgistics Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that Wellgistics Health investors own include NVIDIA (NVDA), Biora Therapeutics (BIOR), Citius Pharmaceuticals (CTXR), Meta Platforms (META) and Advanced Micro Devices (AMD). Company Calendar Last Earnings8/19/2025Today9/04/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (2m+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 MEDS's financial health is in the Yellow zone, according to TradeSmith. MEDS has been in this zone for over 2 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryHealthcare Distributors Current SymbolNASDAQ:MEDS Previous SymbolNASDAQ:WGRX CIK2030763 Webwww.wellgisticshealth.com Phone1-843-302-1785FaxN/AEmployees31Year FoundedN/AProfitability EPS (Trailing Twelve Months)($46.13) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$101.28 million Net Margins-1,100.16% Pretax Margin-1,100.17% Return on EquityN/A Return on Assets-171.81% Debt Debt-to-Equity RatioN/A Current Ratio0.14 Quick Ratio0.10 Sales & Book Value Annual Sales$23.34 million Price / Sales0.13 Cash FlowN/A Price / Cash FlowN/A Book Value($6.35) per share Price / Book-0.15Miscellaneous Outstanding Shares3,200,000Free Float2,267,000Market Cap$3.08 million OptionableN/A Beta-1.77 The 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (NASDAQ:MEDS) was last updated on 9/4/2026 by MarketBeat.com Staff. From Our PartnersThe 2026 beginners Guide to Gold IRAsGold trades near record highs while silver just topped $81 an ounce for the first time ever. Thousands of A...Goldco Direct, LLC | SponsoredA Simple Guide to Options Trading While It's Still FreeA free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...True Market Insiders | SponsoredAre you leaving Social Security money on the table?Most retirement plans still have gaps in them... The quiet ones that don't show up until it's too late to fix....Money Pickle | SponsoredEarth's biggest energy source: near Grand CanyonThe largest energy source on Earth contains 50,000 times every oil and gas reserve on the planet combined - an...Behind the Markets | SponsoredInside the site of Elon’s next major breakthroughInside an ordinary Fremont, California building, Elon Musk is reportedly developing technology he says could e...Monument Traders Alliance | SponsoredHow Long Does $2.5M Last in Retirement?Having $2.5 million saved puts you ahead of most Americans, but how long it lasts depends on the decisions you...SmartAsset | SponsoredRickards Predicts: Trump to buy tiny $2 stock?Jim Rickards believes the Trump administration is about to take a direct stake in a $2 stock sitting on the la...Paradigm Press | SponsoredThe cat is out the bagAlmost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered s...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Wellgistics Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Wellgistics Health With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
